MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
13.15
NaN%
Closed 09:30 07/10 EDT
OPEN
--
PREV CLOSE
13.15
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
41.25
52 WEEK LOW
13.15
MARKET CAP
23.56B
P/E (TTM)
12.82
1D
5D
1M
3M
1Y
5Y
1D
Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer
Benzinga · 1d ago
Pfizer wins FDA label expansion for Padcev plus Merck’s Keytruda in bladder cancer
Seeking Alpha · 2d ago
Bernstein Sticks to Its Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 5d ago
Weekly Report: what happened at ALPMF last week (0629-0703)?
Weekly Report · 6d ago
J.P. Morgan Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 06/29 10:35
Weekly Report: what happened at ALPMF last week (0622-0626)?
Weekly Report · 06/29 09:51
Merck gains EU approval of Keyruda, Padcev combo for bladder cancer
Seeking Alpha · 06/24 11:49
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Benzinga · 06/23 17:46
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.